Market Overview

Halozyme Therapeutics, Inc. (NASDAQ: HALO)

30.83 -0.27 (-0.87%)

Analyst Ratings

DateResearch FirmActionCurrentPT
7/02/20Piper SandlerMaintainsOverweight31.0
7/01/20BenchmarkInitiates Coverage OnBuy39.0
6/15/20CitigroupMaintainsNeutral26.0
5/19/20Canaccord GenuityMaintainsBuy27.0
5/12/20JMP SecuritiesMaintainsMarket Outperform34.0
5/12/20JP MorganMaintainsOverweight23.0
5/12/20BMO CapitalMaintainsOutperform35.0
5/04/20Cantor FitzgeraldReiteratesOverweight39.0
2/25/20BarclaysMaintainsEqual-Weight20.0
2/25/20JP MorganMaintainsOverweight22.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter